Louis-Armstrong

FDA OKs ‘Game Changer’ Radiotracer for Prostate Cancer

WASHINGTON — The FDA approved the first PET imaging agent that targets prostate-specific membrane antigen (PSMA)…

‘Hidden’ Prostate Cancer on Biopsy Usually Means Good Outcome: Study | Health News

By Robert Preidt, HealthDay Reporter (HealthDay) MONDAY, Nov. 23, 2020 (HealthDay News) — Negative biopsies among…